Ongoing efforts to improve the management of patients with diabetes in Bangladesh and the implications

Abstract

It was encouraging to see continued growth in the prescribing and dispensing of long-acting insulin analogues in Bangladesh via the increasing availability of biosimilars. This is likely to continue benefitting all key stakeholder groups.